Hans Van Vlierberghe
Hans Van Vlierberghe
Unknown affiliation
Verified email at
Cited by
Cited by
Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial
AX Zhu, RS Finn, J Edeline, S Cattan, S Ogasawara, D Palmer, ...
The Lancet Oncology 19 (7), 940-952, 2018
Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study
S Blach, S Zeuzem, M Manns, I Altraif, AS Duberg, DH Muljono, I Waked, ...
The lancet Gastroenterology & hepatology 2 (3), 161-176, 2017
Global prevalence, treatment, and prevention of hepatitis B virus infection in 2016: a modelling study
D Razavi-Shearer, I Gamkrelidze, MH Nguyen, DS Chen, P Van Damme, ...
The lancet Gastroenterology & hepatology 3 (6), 383-403, 2018
Systemic inflammation in decompensated cirrhosis: characterization and role in acute‐on‐chronic liver failure
J ClÓria, RE Stauber, MJ Coenraad, R Moreau, R Jalan, M Pavesi, ...
Hepatology 64 (4), 1249-1264, 2016
Tivantinib for second-line treatment of advanced hepatocellular carcinoma: a randomised, placebo-controlled phase 2 study
A Santoro, L Rimassa, I Borbath, B Daniele, S Salvagni, JL Van Laethem, ...
The lancet oncology 14 (1), 55-63, 2013
Clinical course of acute‐on‐chronic liver failure syndrome and effects on prognosis
T Gustot, J Fernandez, E Garcia, F Morando, P Caraceni, C Alessandria, ...
Hepatology 62 (1), 243-252, 2015
Noninvasive diagnosis and monitoring of nonalcoholic steatohepatitis: present and future
A Wieckowska, AJ McCullough, AE Feldstein
Hepatology 46 (2), 582-589, 2007
Adefovir Dipivoxil Therapy for Lamivudine–Resistant Hepatitis B in Pre-and Post-Liver Transplantation Patients
ER Schiff, CL Lai, S Hadziyannis, P Neuhaus, N Terrault, M Colombo, ...
Hepatology 38 (6), 1419-1427, 2003
The present and future disease burden of hepatitis C virus (HCV) infection with today's treatment paradigm
H Razavi, I Waked, C Sarrazin, RP Myers, R Idilman, F Calinas, W Vogel, ...
Journal of viral hepatitis 21, 34-59, 2014
ABT-450, ritonavir, ombitasvir, and dasabuvir achieves 97% and 100% sustained virologic response with or without ribavirin in treatment-experienced patients with HCV genotypeá…
P Andreone, MG Colombo, JV Enejosa, I Koksal, P Ferenci, A Maieron, ...
Gastroenterology 147 (2), 359-365. e1, 2014
Noninvasive diagnosis of liver cirrhosis using DNA sequencer–based total serum protein glycomics
N Callewaert, HV Vlierberghe, AV Hecke, W Laroy, J Delanghe, ...
Nature medicine 10 (4), 429-434, 2004
Association between diabetes, family history of diabetes, and risk of nonalcoholic steatohepatitis and fibrosis
R Loomba, M Abraham, A Unalp, L Wilson, J Lavine, E Doo, NM Bass, ...
Hepatology 56 (3), 943-951, 2012
Functional imaging of neuroendocrine tumors with combined PET/CT using 68Ga‐DOTATATE (DOTA‐DPhe1,Tyr3‐octreotate) and 18F‐FDG
I Kayani, JB Bomanji, A Groves, G Conway, S Gacinovic, T Win, J Dickson, ...
Cancer: Interdisciplinary International Journal of the American Cancerá…, 2008
Ledipasvir and sofosbuvir plus ribavirin in patients with genotype 1 or 4 hepatitis C virus infection and advanced liver disease: a multicentre, open-label, randomised, phase 2á…
M Manns, D Samuel, EJ Gane, D Mutimer, G McCaughan, M Buti, ...
The Lancet Infectious Diseases 16 (6), 685-697, 2016
Effects of fractionated plasma separation and adsorption on survival in patients with acute-on-chronic liver failure
A Kribben, G Gerken, S Haag, S Herget–Rosenthal, U Treichel, C Betz, ...
Gastroenterology 142 (4), 782-789. e3, 2012
Biliary strictures following liver transplantation: past, present and preventive strategies
S Sharma, A Gurakar, N Jabbour
Liver Transplantation 14 (6), 759-769, 2008
Accuracy and reproducibility of transient elastography for the diagnosis of fibrosis in pediatric nonalcoholic steatohepatitis
V Nobili, F Vizzutti, U Arena, JG Abraldes, F Marra, A Pietrobattista, ...
Hepatology 48 (2), 442-448, 2008
Entecavir is superior to lamivudine in reducing hepatitis B virus DNA in patients with chronic hepatitis B infection
CL Lai, M Rosmawati, J Lao, H Van Vlierberghe, FH Anderson, N Thomas, ...
Gastroenterology 123 (6), 1831-1838, 2002
Experimental mouse models for hepatocellular carcinoma research
F Heindryckx, I Colle, H Van Vlierberghe
International journal of experimental pathology 90 (4), 367-386, 2009
Drug‐induced cholestasis
MS Padda, M Sanchez, AJ Akhtar, JL Boyer
Hepatology 53 (4), 1377-1387, 2011
The system can't perform the operation now. Try again later.
Articles 1–20